| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.18 | 1e-07 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-07 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-07 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-07 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-07 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-07 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-07 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-07 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.16 | 6e-07 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.27 | 8e-07 |